NCT06512818View on ClinicalTrials.gov

Effect of Psiguavin for Obesity Treatment (PSIGUAVIN)

PHASE1/PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 8, 2025

Primary Completion Date

December 19, 2026

Study Completion Date

December 19, 2027

Conditions
ObesityOverweight or Obesity
Interventions
DIETARY_SUPPLEMENT

Psiguavin

A purified guava extract will be used, enriched in psiguavin

DRUG

Placebo

Capsules with the same characteristics that Psiguavin intervention but filled with a placebo compound

Trial Locations (1)

30107

Faculty of Nursing. Catholic University of Murcia, Murcia

All Listed Sponsors
lead

Universidad Católica San Antonio de Murcia

OTHER